List of Excipients in API sulindac
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing sulindac
Detailed excipient profiles for sulindac
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sulindac drug variants containing CELLULOSE, MICROCRYSTALLINE
sulindac drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
sulindac drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sulindac | 0378-0427 |
| Mylan Institutional Inc | sulindac | 51079-667 |
| >Company | >Ingredient | >NDC |
sulindac drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: MAGNESIUM STEARATE
sulindac drug variants containing MAGNESIUM STEARATE
sulindac drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
sulindac drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | sulindac | 53808-0303 |
| State of Florida DOH Central Pharmacy | sulindac | 53808-0799 |
| >Company | >Ingredient | >NDC |
sulindac drug variants not containing POVIDONE
Excipient focus: POVIDONE K29/32
sulindac drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | sulindac | 0904-6216 |
| PuraCap Laboratories LLC dba Blu Pharmaceuticals | sulindac | 24658-770 |
| Epic Pharma LLC | sulindac | 42806-018 |
| A-S Medication Solutions | sulindac | 50090-4976 |
| >Company | >Ingredient | >NDC |
sulindac drug variants not containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sulindac | 0378-0427 |
| Actavis Pharma Inc | sulindac | 0591-5661 |
| Major Pharmaceuticals | sulindac | 0904-7334 |
| STAT Rx USA LLC | sulindac | 16590-211 |
| Aidarex Pharmaceuticals LLC | sulindac | 33261-100 |
| A-S Medication Solutions | sulindac | 50090-0529 |
| A-S Medication Solutions | sulindac | 50090-2093 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
sulindac drug variants containing POVIDONE K30
sulindac drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
sulindac drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sulindac | 0378-0427 |
| Mylan Institutional Inc | sulindac | 51079-667 |
| >Company | >Ingredient | >NDC |
sulindac drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
sulindac drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sulindac | 0378-0427 |
| Mylan Institutional Inc | sulindac | 51079-667 |
| State of Florida DOH Central Pharmacy | sulindac | 53808-0303 |
| State of Florida DOH Central Pharmacy | sulindac | 53808-0799 |
| >Company | >Ingredient | >NDC |
sulindac drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
sulindac drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
sulindac drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
sulindac drug variants containing STARCH, CORN
sulindac drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
sulindac drug variants containing STEARIC ACID
sulindac drug variants not containing STEARIC ACID
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
